IL33 and atopic eczema: The latest studies confirm the expression of IL-33 receptors in atopic dermatitis, but indicate that IL-18 may be of key importance in maintaining the independence of IL-33 activation of ILC2 during skin inflammation, hence the low effectiveness of IL-33 inhibition in atopic dermatitis [142].